Adcock Ingram Holdings Limited

Adcock Ingram Holdings Limited, a pharmaceutical preparation manufacturer headquartered in ZA, reported total carbon emissions of approximately 131.5 billion kg CO2e for the fiscal year 2024. This figure encompasses Scope 1 emissions totalling about 17.2 billion kg CO2e, Scope 2 emissions amounting to approximately 52.6 billion kg CO2e, and Scope 3 emissions of around 63.5 billion kg CO2e.

For the preceding year, 2023, the company's total emissions were approximately 134.0 billion kg CO2e. Scope 1 emissions for 2023 were reported as about 21.2 billion kg CO2e, with Scope 3 emissions at approximately 60.3 billion kg CO2e. Scope 2 data for 2023 was not disclosed.

Adcock Ingram Holdings Limited's emissions data for the fiscal years 2015, 2016, and 2022 is not fully available, with no disclosed emissions data reported for these periods.

The company's reporting indicates a commitment to measuring and managing its environmental impact, with disclosed upstream categories for Scope 3 emissions and Scope 1 and 2 emissions data available for recent reporting years. Production emission factors are also provided, including carbon emissions per full-time employee and per square metre.

Adcock Ingram Holdings Limited has not disclosed any specific reduction targets or participation in initiatives like the Science Based Targets initiative (SBTi) or the Climate Pledge.